🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Annabel Goodwin

The University of Sydney

ORCID: 0000-0002-8859-9980

Also affiliated with Royal Prince Alfred Hospital, Concord Repatriation General Hospital, MRC Clinical Trials Unit at UCL

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial.

398 citations

Sara A. Hurvitz, Lida A. Mina, Hope S. Rugo, Ki Hoon Lee, Anthony Gonçalvès +15 more

121 citations

James G. Dowty, Jeanette C. Reece, Grant Lee, Allyson Templeton, John‐Paul Plazzer +95 more

22 citations

Khalid Mahmood, Jihoon E. Joo, Mark Clendenning, Peter Georgeson, Julia Como +45 more

1 citations

Khalid Mahmood, Julia Como, Mark Clendenning, Jihoon E. Joo, Peter Georgeson +28 more

6 citations

Reena S. Cecchini, Eleanor Harris, Eleftherios P. Mamounas, Daniel G. Stover, Patricia A. Ganz +12 more

1 citations

Khalid Mahmood, Julia Como, Mark Clendenning, Jihoon E. Joo, Peter Georgeson +29 more